Skip to main content

Table 3 Potential drugs were provided by CMap database according to hub genes

From: Identifying potential biomarkers for the diagnosis and treatment of IgA nephropathy based on bioinformatics analysis

Cmap name

Mean

N

Enrichment

p

Percent non-null

verteporfin

-0.859

3

-0.99

0

100

moxonidine

-0.646

3

-0.896

0.00218

100

procaine

-0.597

5

-0.848

0.00024

100

prenylamine

-0.614

4

-0.814

0.00225

100

sulfadoxine

-0.561

3

-0.795

0.01757

100

cortisone

-0.532

3

-0.794

0.01785

100

buspirone

-0.525

4

-0.778

0.00501

100

STOCK1N-35,215

-0.553

3

-0.768

0.02552

100

primidone

-0.251

4

-0.699

0.01725

50

emetine

-0.454

4

-0.687

0.02067

75